| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2010 | CN100579527C Compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and use method thereof |
| 01/13/2010 | CN100579526C Compound sustained-release pellet tablet containing nifedipine and atenolol and preparation thereof |
| 01/13/2010 | CN100579525C Sustained release preparation of licardipine hydrochloride and its preparing process |
| 01/13/2010 | CN100579524C Method of preparing simvastatin sustained-release microsphere carried series |
| 01/13/2010 | CN100579523C Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof |
| 01/13/2010 | CN100579522C Pasting agent |
| 01/13/2010 | CN100579521C Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/13/2010 | CN100579520C Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 01/13/2010 | CN100579519C Use of patchouli alcohol in preparing medicament for preventing and controlling senile dementia |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/13/2010 | CN100579516C Vaginal effervescence tablet composition containing solid lipid |
| 01/13/2010 | CN100579513C Preparation method of lung targeting emodin polylactic acid microsphere |
| 01/13/2010 | CN100579512C Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 01/13/2010 | CN100579511C Ratification of highly purified tranexamic acid injection and quality standard thereof |
| 01/13/2010 | CN100579510C Precursor micelle preparation and its production process |
| 01/13/2010 | CN100579508C Oral-cleaning orally disintegrating tablet and preparing technique thereof |
| 01/13/2010 | CN100579373C Compositions containing opioid antagonists |
| 01/12/2010 | US7645903 immunoglobulins; affinity chromatography |
| 01/12/2010 | US7645898 Selective androgen receptor modulators and method of use thereof |
| 01/12/2010 | US7645887 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 01/12/2010 | US7645885 (E)-Methyl 3-(1,2,3,4,8,8 alpha -hexahydro-8 alpha -methylspiro[1',3'-dithiolane-2',6(7H)naphthalen]-1-yl)acrylate; for treating or preventing diseases ( prostate cancer, benign prostatic hyperplasia, reproductive disorders, and male hypogonadism) associated with androgen binding to the androgen receptor |
| 01/12/2010 | US7645873 6-azido-2,3,4-tetra-O-benzyl-6-deoxymethylgalactopyranoside ; for treating cancer or autoimmune disorders |
| 01/12/2010 | US7645871 Tumor inhibition by modulating sprouty expression of activity |
| 01/12/2010 | US7645870 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 01/12/2010 | US7645869 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 01/12/2010 | US7645864 N-demethyl-N-isopropyl-12-methoxy-11-oxo-8,9-anhydroerythromyc in A-6,9-hemiacetal fumarate; treating with ethyl acetate; reduced content of residual solvent and high suitability for formulation |
| 01/12/2010 | US7645863 Adding a second organic solvent to a concentrated moxidectin solution to obtain a weight ratio of 2:I to 6:I with respect to the first solvent; cooling and recovering crystals of 94-96% purity being 2-5% purer than the amorphous form; veterinary medicine; antithelmintics; parasiticides |
| 01/12/2010 | US7645816 Water-soluble compositions of bioactive lipophilic compounds |
| 01/12/2010 | US7645803 containing a saccharide for use in the treatment of dermal disorders including H2O; a saccharide; a nonionic surfactant such as polyoxyethylene glycol sorbitan monostearate, a polymeric agent selected from a bio-adhesive agent, gelling agent; film forming agent; phase change agent; adjuvant; propellant |
| 01/12/2010 | US7645802 Controlled release, once daily formulation; reducing seizure side effects; antidepressant |
| 01/12/2010 | US7645800 17-phenyl trinor PGF2 alpha cyclopropylmethyl amide, for example; stimulates hair growth of scalp, eyebrows or eyelashes or restores hair color to depigmented hair |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645798 N-(2-hydroxyalkanoyl)-N,N′-dialkylureas and a process for their preparation |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645796 Amino acid composition promoting collagen synthesis |
| 01/12/2010 | US7645795 Administering a nutritional supplement phosphatidylcholine, linoleic acid and alpha linoleic acid in combination with mineral; inhibit the disease progression or delay the symptoms; using nutraceuticals to treat neurodegenerative diseases |
| 01/12/2010 | US7645794 containing ethyl pyruvate and a therapeutically effective amount of at least one alpha -hydroxy branched-chain amino acid metabolite selected from alpha-hydroxyisocaproic acid, alpha -hydroxy- beta -methylvaleric acid, and alpha -hydroxy-isovaleric acid; time-release agents; nutritional supplement |
| 01/12/2010 | US7645793 Effective ingredient and basic agent; foam suppression |
| 01/12/2010 | US7645791 5-tert-Butyl-4-hydroxy-2-methyl-biphenyl-3-carboxylic acid (2-chloro-4-nitro-phenyl) -amide; chemical uncouplers like for the treatment of obesity |
| 01/12/2010 | US7645790 Hydroisoindoline tachykinin receptor antagonists |
| 01/12/2010 | US7645789 Modulators of ATP-Binding Cassette transporters; Cystic Fibrosis Transmembrane Conductance Regulator; N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide |
| 01/12/2010 | US7645788 Treating breast cancer cells which are both estrogen-dependent and estrogen-negative; chemical systhesis by reacting indole-3-carbinol with an oxidizing agent in a solvent, cyclization, purification |
| 01/12/2010 | US7645787 4'-((2-fluoro-4-methylphenyl)methyl)-1'-isopropyl-5'-methyl-1H-pyrazole-3'-O-(6-carbomethoxy)- beta -D-glucopyranoside; 4-[(3-fluoro-4-methoxyphenyl)methyl]-1-isopropyl-5-methyl-1H-pyrazole-3-O- beta -D-glucopyranoside; reducing reanal glucose reabsorption |
| 01/12/2010 | US7645786 Substituted arylpyrazoles |
| 01/12/2010 | US7645785 Farnesoid-X-receptors (FXR) agonists; diabetes and dyslipidemia; 2,N-dicyclohexyl-2-(2-phenyl-benzoimidazol-1-yl)-acetamide hydrogen chloride |
| 01/12/2010 | US7645784 Benzimidazole derivatives |
| 01/12/2010 | US7645783 Halogenated benzamide derivatives |
| 01/12/2010 | US7645782 Ethyl (2Z,5S,6E)-5-(tert-Butyl-dimethyl-silanyloxy)-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)-hepta-2,6-dienoate; (3S)-3-(tert-Butyl-dimethyl-silanyloxy)-tetrahydrofuranone; breast , epidermoid, ovarian, lung, prostate cancer, cervix carcinoma, cancer of the bladder or leukemia |
| 01/12/2010 | US7645781 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 01/12/2010 | US7645780 N-[(1S,2R)-3-{[1-(3-bromophenyl)cyclopropyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide hydrochloride; for Alzheimer's disease; inhibitors of beta-secretase |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645778 Heteroaryl compounds as P2Y1 receptor inhibitors |
| 01/12/2010 | US7645777 Switching device |
| 01/12/2010 | US7645776 (R)-1-{2-[3-(4-Methoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-2-phenoxy-ethanone; carnitine-dependent palmitoyltransferases (CPTs); reduce liver beta -oxidation, consequently inhibit gluconeogenesis and therefore counteract hyperglycemia |
| 01/12/2010 | US7645775 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645773 Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase |
| 01/12/2010 | US7645772 Treatment of metabolic disorders |
| 01/12/2010 | US7645771 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645769 Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645767 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| 01/12/2010 | US7645766 Method for treatment of depression and depressive mood disorders |
| 01/12/2010 | US7645765 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645763 dipeptidylpeptidase-IV inhibitors; antidiabetic agents, antiarthritic agents, obesity, allograft transplantation, and osteoporosis caused by calcitonin; 1,3-disubstituted-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)-xanthine compounds |
| 01/12/2010 | US7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645759 (4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin8yloxy-methyl) benzenesulfonylamino] tetrahydropyran-4carbonyl}-piperazin-1-yl)-5-oxo-pentyl] trimethyl-ammonium chloride, dihydrochloride; asthma or chronic bronchitis |
| 01/12/2010 | US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | US7645756 Nitrogenous fused heteroaromatic ring derivative |
| 01/12/2010 | US7645755 5-Cyano-1H-imidazole-2-carboxylic acid [4-(3,6-dihydro-2H-pyran-4-yl)-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645753 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives |
| 01/12/2010 | US7645752 Inhibitors of norepinephrine reuptake; 5-HT2A receptor inhibitors; N,N-dimethyl-N-{2-[3-(phenylsulfonyl)-1H-indol-5-yl]ethyl}amine; 3-(phenylsulfonyl)-7-(2-pyrrolidin-1-ylethyl)-1H-indole; |
| 01/12/2010 | US7645751 Mandelic acid derivatives and their use as thrombin inhibitors |
| 01/12/2010 | US7645750 Using serotonin and/or dopamine type 2 receptor antagonists; peri or post menopause; safe alternative to estrogen replacement therapy |
| 01/12/2010 | US7645749 contains ester linkage of a nitric oxide (NO)-releasing moiety to a sterol or stanol compound; useful for treating atherosclerosis, hypercholesterolemia, hyperlipidemia, hypertension, thrombosis, Type II diabetes, dementia, Alzheimer's disease and aging |
| 01/12/2010 | US7645748 include a phosphate linker, at least one nitrate group that releases nitric oxide (NO), and a sterol or stanol group; useful for treating atherosclerosis, hypercholesterolemia, hyperlipidemia, hypertension, thrombosis, Type II diabetes, dementia, Alzheimer's disease and aging |
| 01/12/2010 | US7645747 Improved pharmacokinetic properties, oral bioavailability; side effect reduction |
| 01/12/2010 | US7645746 Composition for reducing malodor impression on inanimate surfaces |
| 01/12/2010 | US7645745 Propionic Acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-4-methyl-3-propionyloxy-tetrahydro-furan-2-ylmethyl ester; inhibit RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase |
| 01/12/2010 | US7645744 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 01/12/2010 | US7645743 Administering immunity linkers with more than one binding site, wherein second site binds to target and individual has pre-existing cellular or humoral immune response to first site; high speed response to public health needs such as pandemic infections; biological warfare; vaccines |
| 01/12/2010 | US7645742 administering a formulation containing creatine, L-arginine- alpha -ketoglutarate, D-ribose, L-carnitine, L-citrulline, and pyruvate to a mammal performing a physical activity 15-30 minutes before initiation of the physical activity; increases endurance and muscle mass of the person |
| 01/12/2010 | US7645738 18-membered nitrobenzyl- and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites and a process for their preparation |
| 01/12/2010 | US7645736 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 01/12/2010 | US7645732 administering antiviral agents, very low density lipoproteins (VLDL) assembly inhibitors, such as small interfering RNA or antisense oligonucleotide directed against apolipoprotein B, or microsomal triglyceride transfer protein (MTP) inhibitors, to inhibit release of HCV from an HCV-infected cells |
| 01/12/2010 | US7645595 Culturing epidermal keratinocytes on collagen gel layer containing human fibroblasts, exposing to air, and culture contains matrix metalloproteinase inhibitor such as N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride |
| 01/12/2010 | US7645465 Includes acid-treatment of ginseng and bio-converting treatment, such as lactic acid bacterial fermenting and intestinal bacterial fermenting process, extracting acid treated ginseng with organic solvent to obtain organic extract, fermenting organic extract with lactic-acid bacteria Bifidobacterium KK-1 |
| 01/12/2010 | US7645461 Method of treating cerebral ischemia with hydrogenation products of frankincense extracts |
| 01/12/2010 | US7645460 Dosage forms of risedronate |
| 01/12/2010 | US7645459 Oral dosage form having pharmaceutically effective absorption comprising 1-500 mg of a bisphosphonate which is selected from risedronate and acids, salts, and esters thereof, 10-500 mg of EDTA, and a delayed release mechanism to deliver the bisphosphonate and the EDTA in the lower gastrointestinal tract |
| 01/12/2010 | US7645441 Compositions and methods in cancer associated with altered expression of PRLR |
| 01/12/2010 | US7645419 Killing microorganisms |
| 01/12/2010 | CA2573404C Substituted oxindole derivatives and medicaments containing the same |
| 01/12/2010 | CA2560489C Pyranone compounds useful to treat retroviral infections |